Post by
Nohandledzep on Mar 13, 2014 6:52pm
The CC
Worth listening to.
if nothing else, you will realize how futile the turnaround appears to be. I heard nothing near term beyond another placement. Contrary to what the previous management lead us to believe, nothing is close...Nothing.
This only confirms my theory that the last 24 months of the previous regime's existence were focused solely on keeping them existing. As far as commercial advancement of Urocidin, or anything else of significance, it was the tire fire we expected.
It is worth noting that the operation will be moved to Montreal, with the Belleville operation wrapped up under something called Econiche Corp. I have to commend them on running with their greatest commercial branding success, I can only assume Agent Orange Corporation was unavailable.
Lastly, there was no sense of urgency whatsoever around the share price. They did acknowledge that they needed better communication outside of Canada and unsure of whether analyst coverage existed.
If the goal was to provide some final incentive for long term shareholder to bail out, in an effort to introduce a less caustic shareholder base, it was a 9 out of 10!
Comment by
Pogo3 on Mar 13, 2014 10:03pm
Graeme and his BOD totally mismanaged BNC during their tenure, the shareholders should be compensated for his bafoonery
Comment by
Tson99 on Mar 14, 2014 10:20am
I'm missing something...how are we receiving 43 cents/share? Thanks,